For years, mental health patients and their doctors have often endured a trial-and-error process to figure out which drugs would best help them manage their illness. With the explosion of genetic testing, patients can now take a DNA test to receive psychiatric drug recommendations based on their genetic makeup. But – as these new tests take psychiatry by storm – an NECIR’s recent investigation finds that the research behind them is scant, incomplete, or biased, and the potential for conflict of interest is enormous.
Join NECIR’s Senior Investigative Reporter Beth Daley, Huffington Post Healthy Living Editor Erin Schumaker, Dr. Joseph Goldberg of the Icahn School of Medicine at Mount Sinai, Dr. Daniel Carlat of Tufts University School of Medicine, and Dr. John Grohol of PsychCentral to learn more about this emerging industry in mental health care.
The live chat is now closed, but you can leave us a comment or question in the Comments section below. You can also join us on October 15th at 7pm at the studios of WGBH for discussion on genetics. More information here.